Trial · NCT03364491
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Maternal Death or Transfusion of Packed Red Blood Cells | Tranexamic Acid | 201 | Participants | ||
| Number of Participants With Maternal Death or Transfusion of Packed Red Blood Cells | Placebo | 233 | Participants | ||
| Number of Participants With Estimated Blood Loss Greater Than 1 Liter During Delivery | Tranexamic Acid | 339 | Participants | ||
| Number of Participants With Estimated Blood Loss Greater Than 1 Liter During Delivery | Placebo | 368 | Participants | ||
Number of Mothers Who Died or Had Thromboembolic Events (Venous or Arterial), Ischemic Stroke, Myocardial Infarction, New-onset Seizure Activity, or Were Admitted to the Intensive Care Unit for More Than 24 Hours | Tranexamic Acid | 35 | Participants | ||
Number of Mothers Who Died or Had Thromboembolic Events (Venous or Arterial), Ischemic Stroke, Myocardial Infarction, New-onset Seizure Activity, or Were Admitted to the Intensive Care Unit for More Than 24 Hours | Placebo | 32 | Participants | ||
| Number of Participants Who Were Transfused With Other Blood Products | Tranexamic Acid | 29 | Participants | ||
| Number of Participants Who Were Transfused With Other Blood Products | Placebo | 31 | Participants | ||
| Number of Participants Who Were Transfused With 4 or More Units of Packed Red Blood Cells | Tranexamic Acid | 20 | Participants | ||
| Number of Participants Who Were Transfused With 4 or More Units of Packed Red Blood Cells | Placebo | 19 | Participants | ||
| Number of Participants With a Thromboembolic Event (Venous or Arterial), Ischemic Stroke, or Myocardial Infarction | Tranexamic Acid | 12 | Participants | ||
| Number of Participants With a Thromboembolic Event (Venous or Arterial), Ischemic Stroke, or Myocardial Infarction | Placebo | 13 | Participants | ||
| Number of Participants With Seizure Activity That Was Not Seen Prior to Study Enrollment | Tranexamic Acid | 2 | Participants | ||
| Number of Participants With Seizure Activity That Was Not Seen Prior to Study Enrollment | Placebo | 0 | Participants | ||
| Number of Participants With Postpartum Infectious Complications | Tranexamic Acid | 162 | Participants | ||
| Number of Participants With Postpartum Infectious Complications | Placebo | 125 | Participants | ||
| Number of Participants Who Were Treated With Uterotonics Other Than Oxytocin | Tranexamic Acid | 649 | Participants | ||
| Number of Participants Who Were Treated With Uterotonics Other Than Oxytocin | Placebo | 732 | Participants | ||
| Number of Participants Who Received Surgical or Radiologic Interventions to Control Bleeding and Related Complications | Tranexamic Acid | 233 | Participants | ||
| Number of Participants Who Received Surgical or Radiologic Interventions to Control Bleeding and Related Complications | Placebo | 231 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03364491/results